A Focus on VEGF TKIs

Experts discuss the optimal use of VEGF-targeted tyrosine kinase inhibitors for patients with GI malignancies in this this podcast series that includes downloadable summary slidesets.

Share

Program Content

Activities

  • Sequencing Later-Line CRC Tx
    Optimizing the Timing and Sequencing of Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 29, 2021

    Expires: April 28, 2022

  • <i>Pearls</i>: Later-line CRC Tx
    Podcast Pearls: Optimizing the Timing and Sequencing of Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 29, 2021

    Expires: April 28, 2022

  • Dosing in Later-Line CRC Tx
    Optimal Dosing Strategies With Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 21, 2021

    Expires: October 20, 2022

  • <i>Pearls:</i> Dosing Rego/TAS-102
    Podcast Pearls
    Optimal Dosing Strategies With Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 21, 2021

    Expires: October 20, 2022

  • Key Factors in Later-Line CRC Tx
    Key Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 17, 2021

    Expires: December 16, 2022

  • <i>Pearls</i>: Key Factors in Later-Line CRC Tx
    Podcast Pearls: Key Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 20, 2021

    Expires: December 19, 2022

  • Rego and TAS-102 for CRC
    Evolving Treatment Landscape With Regorafenib and TAS-102 in Metastatic Colorectal Cancer
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 06, 2022

    Expires: April 05, 2023

  • <i>Pearls</i>: Rego and TAS-102 for CRC
    Podcast Pearls: Evolving Treatment Landscape With Regorafenib and TAS-102 in Metastatic Colorectal Cancer
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 06, 2022

    Expires: April 05, 2023

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma